Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-090830
Filing Date
2024-08-05
Accepted
2024-08-05 16:30:58
Documents
1
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11591
  Complete submission text file 0000950170-24-090830.txt   13165
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CEREVEL THERAPEUTICS, INC. 51 ASHTOR PLACE NEW YORK NY 10003
Business Address
Renger John (Reporting) CIK: 0001830363 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 241175264